Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reckon Organics is an India-based pharmaceutical company that specializes in the development, manufacture, and export of Active Pharmaceutical Ingredients (APIs) and specialty chemical intermediates. Established in 1998 and headquartered in Vadodara, Gujarat, the company has built a strong reputation for its expertise in complex chemical synthesis, particularly in the production of antifungal agents like Fluconazole and Terbinafine Hydrochloride. Reckon Organics operates manufacturing facilities that adhere to Good Manufacturing Practice (GMP) standards, enabling them to supply high-quality products to pharmaceutical companies worldwide. In addition to its catalog of APIs, the company offers contract manufacturing and custom synthesis services tailored to the specific needs of its global clientele. Their focus on quality and regulatory compliance has made them a reliable partner in the global pharmaceutical supply chain.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reckon Organics.